$GTCH is aiming qTerm for telemedicine including r
Post# of 8463
(Total Views: 135)
Posted On: 03/09/2021 8:36:47 AM
$GTCH is aiming qTerm for telemedicine including remote locations where conventional communication services are not available. The mobile application architecture is aimed to identify the user’s location, with or without the use of GPS, working with the long-range radio. Users will be able to send vitals via qTerm mobile application, including their geographical location, and communicate via audio using the radio system anywhere around the globe.
GBT Tokenize expects to complete an improved version of qTerm hardware by May 2021 and to start incorporating its smartphone mobile application infrastructure. Initial testing with long-range radio prototype is expected to start by August 2021. The company plans to perform a series of testing of the fully integrated system as a comprehensive telemedicine solution by the end of the year.
There is no guarantee that the Company will be successful in researching, developing or implementing this research. In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed and granted regulatory approval, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps.
GBT Tokenize expects to complete an improved version of qTerm hardware by May 2021 and to start incorporating its smartphone mobile application infrastructure. Initial testing with long-range radio prototype is expected to start by August 2021. The company plans to perform a series of testing of the fully integrated system as a comprehensive telemedicine solution by the end of the year.
There is no guarantee that the Company will be successful in researching, developing or implementing this research. In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed and granted regulatory approval, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps.
(0)
(0)